BEINHEIM, FRANCE

Our Beinheim, France facility houses softgel development and manufacturing operations with capacity of 4.5 billion softgel capsules per year. Its featured OptiGel™ Bio technology enables the potential oral delivery of macromolecule therapies. It incorporates enteric coating and permeation enhancers to first deliver active macromolecules to the absorption site and then secondly to pass through the absorption site to enter circulation. Within the Catalent network, we offer a broad range of integrated formulation and analytical services to solve your most difficult development and manufacturing challenges.

Size: 78,100 ft²

CAPABILITIES:

• Formulation Development and Manufacturing services for:
  • Controlled Substances
  • Highly Potent Compounds
  • Hormones
• Rx and OTC Softgel development and manufacturing

FEATURED TECHNOLOGIES

• OptiForm® Solution Suite
• OptiGel™ Bio Technology
• RP Scherer Softgel Technology

ACCREDITATIONS

• EMA Approved
• FDA Approved
• ANSM
• ANVISA
• CFDA (China)
• MOH (Saudi Arabia)

SALES INQUIRIES

Reach out to one of our experts to discuss any of our offerings or a specific solution for your project challenges.

CAREERS

We recognize talent is our most important asset. To explore a career with Catalent, visit our Careers Section to submit your resume.

GENDER EQUALITY

Catalent Limoges is committed to gender equality, the site scored 99/100 on equity of treatment between men and women index, according to French laws.

Conformément au décret n° 2019-15 du 8 janvier 2019 l’index égalité professionnel est, pour le site de Limoges (87) : 99